SOPHIA ANTIPOLIS, France – December 18, 2025 │ KnowMade’s Patent Analyst Elodie Bovier, PhD, explores patent trends shaping mRNA delivery in ONdrugDelivery’s Dec 2025 issue.
KnowMade maps innovation in mRNA delivery in new article
KnowMade is proud to announce the publication of its latest contribution in the December 2025 issue of ONdrugDelivery, titled “Mapping Innovation in mRNA Delivery Through Patent Trends.” Authored by Elodie Bovier, PhD, Biotechnology & Life Sciences Analyst at KnowMade, the article offers a detailed examination of the evolution of therapeutic messenger RNA (mRNA) technologies through the lens of intellectual property.
This article sheds light on how growing patent activity in the mRNA delivery field reflects both the rapid expansion and the increasing maturity of this cutting-edge biotechnology sector. Dr. Bovier’s analysis highlights how innovation in mRNA delivery systems, particularly lipid nanoparticles (LNPs), has driven strategic patent filings and, increasingly, patent litigation.
We extend our sincere thanks to the editorial team at ONdrugDelivery for the opportunity to contribute to Issue #181: Delivering Cell & Gene Therapeutics.
Read the article: Mapping Innovation in mRNA Delivery Through Patent Trends
Full issue available here: ONdrugDelivery Issue #181
KnowMade’s expertise: knowing where patents lead
This contribution highlights the type of strategic patent intelligence that KnowMade delivers to its clients through tailored services, patent monitoring, and comprehensive reports on mRNA technologies:
- Therapeutic mRNA Patent Monitor: Our quarterly monitoring service tracks global patent activity in mRNA-based therapies and delivery technologies.
- Previous Report on Therapeutic mRNA: An in-depth landscape analysis of key players, IP dynamics, and market trends related to Self-amplifying RNA vaccines, mRNA Cancer Therapies, and RNA vaccine
- Upcoming Report on LNPs for Nucleic Acid Delivery (2026): Stay tuned for our forthcoming publication on LNP innovations, patent strategies, and emerging biotech players.
For more information on our mRNA-related services or to subscribe to our patent monitoring solutions, please visit www.knowmade.com or contact us directly at contact@knowmade.fr.
Press contact
contact@knowmade.fr
Le Drakkar, 2405 route des Dolines, 06560 Valbonne Sophia Antipolis, France
www.knowmade.com
About KnowMade
KnowMade is a technology intelligence and IP strategy consulting company specialized in analyzing patents and scientific publications. The company helps innovative companies, investors, and R&D organizations to understand competitive landscape, follow technological evolutions, reduce uncertainties, and identify opportunities and risks in terms of technology and intellectual property.